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Background: Although a very small number of Japanese hospitals had been performing robotic surgery before
2011, the number now using it is increasing rapidly due to the application of health insurance to robotic surgery
for prostate cancer (PCa) since April, 2012. We report our initial experience of treating 100 patients by robot-assisted
radical prostatectomy (RARP) with a focus on constitutional introduction and implementation based on minimal
invasive surgery center (MISC) and patient outcomes.
Methods: The MISC involved all of the hospital sections related to robotic surgery including four surgery
departments, anesthesiology, operating room nurses, medical engineers. The data were prospectively collected
from the first 100 consecutive patients who underwent RARP under supervision of MISC for localized PCa from
October 2010 to December 2012.
Results: During the period of our initial 100 cases of RARP, the gynecology, respiratory and digestive surgery
departments performed initial cases of 20, 33 and 23 robotic surgeries under control of MISC. Peri-operative
complications in RARP appeared to be minimal with no cases of intra-operative open conversion. The positive surgical
margin rate was 19% for the entire series. At the median follow-up time of 11.9 months, 91% of patients had
undetectable PSA levels, and 76% of patients were not using pads. Sequential urinary functional data indicated a
significant beneficial effect on lower urinary tract symptoms beyond cancer control over a period of several months.
Although the pre-operative potent patient number was small, the transitions of constant potency recovery at precise
time points were shown according to different nerve sparing procedures.
Conclusions: This is the first report of an initial 100 RARP cases that were implemented using the constitutional
framework of an academic institution. The MISC is providing immeasurable benefits from the aspects of patient safety
and education for the robotic surgical team. RARP is a safe and efficient method for achieving PCa control together
with functional preservation, even during the initial trial for this procedure.
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Prostate cancer (PCa) has been the most common non-
cutaneous malignancy in United States (US). men since
1984, now accounting for one quarter of all such cancers
[1]. The Recent age adjusted incidence rate of PCa in
Japan was 15.1/100,000 population which is a relatively
low risk compared to 90 to 110/100,000 population rate in
western countries because PCa incidence varies by race/
ethnicity [2]. Although the specific cause of PCa initiation
and progression are not yet known, considerable evidence
suggests that both genetics and environment play a role in
the origin and evolution of this disease. Throughout the
history of definitive therapy for localized PCa, surgical
therapy has played a central role in the trend toward min-
imal invasive technique. Robot-assisted radical prostatec-
tomy (RARP) using the da Vinci surgical system started
in 2000 [3], and has spread rapidly retaining the con-
cept of minimal invasive surgery. Now, it has become
the established surgical treatment for localized PCa in
the US [4]. The magnified 3-D view, useful scissors with
multi-joints, and the ease of the manipulation of the da
Vinci system have provided surgeons with exceptional
detail of the pelvic anatomy and made radical prosta-
tectomy a minimally invasive surgery. As a result, RARP
could be an epoch-making surgical procedure with which
we could achieve the three competing goals of radical
prostatectomy; that is, cancer control, urinary continence
and erectile function [5].
Although RARP was introduced in 2006 in Japan, the
spread of RARP has been very slow because of off-label
application of Japanese health insurance at that time. How-
ever, the Japanese Ministry of Health, Labor and Welfare
admitted the application of health insurance for RARP on
April 2012; therefore, the rapid spread of RARP is ex-
pected. A concern with regard to the rapid spread of a
new surgical innovation is the issue of patient safety. Re-
duced patient safety occurs due to insufficient preparation
and inadequate surgical technique during the introduction
of a new technology. To eliminate such concerns, the
introduction and implementation of robotic surgeries in
our institution were controlled by the minimal invasive
surgery center (MISC), which runs robotic surgeries com-
prehensively not only in urology but also in other surgical
departments. In this study, we report our initial experi-
ence of 100 patients treated by RARP with a focus on con-
stitutional introduction and implementation based on a
MISC and patient outcomes based on the concept of pen-
tafecta [6].
Methods
Introduction and implementation of robotic
surgery -Comprehensive management by a MISC-
Our institution purchased the daVinci S robot on August,
2010 in the order of eighth in Japan. Two months later,the first RARP case was performed by the chairman of
urology (A.T.) and his robotic surgical team. MISC was
organized six months after the first RARP, and this depart-
ment consisted of all the departments related to robotic
surgery such as anesthesiology, urology, gynecology, re-
spiratory surgery, digestive surgery, operation room nurses
and medical engineers. From the view of safe implementa-
tion of robotic surgery, each surgery was performed under
the supervision of the MISC. For instance, a certificate for
surgery type and the console surgeon were authorized by
MISC. Specifically, the MISC has a “termination order”
authority, which is applied when there is excessive bleed-
ing or surgical time [Figure 1]. Robotic surgery must be
changed into other types of surgery such as open conver-
sion once the order is given. Each robotic surgery case in
four surgery departments is checked and discussed pre-
and post-operatively in the regular meeting held by MISC
twice a month. MISC renovated a wide operating theater
for only robotic surgery, and this theater was separate
from the conventional operating theaters [Figure 2].
Data collection
Pre-, intra and post-RARP data collection of 100 cases
was performed in prospective manner. The median
(range) follow-up period was 11.9 (1.3 - 27.3) months. No
patients were lost during follow-up. The collected data
were categorized as follows: 1) pre-operative characteris-
tics, 2) peri-operative data, 3) peri-operative complica-
tions, 4) pathological findings, 5) oncological outcome, 6)
urinary function outcome, and 7) sexual function out-
come. Biochemical recurrence (BCR) was defined as when
the serum PSA level exceeded 0.2 ng/ml or when a radical
prostatectomy was carried out and the PSA did not
decrease below 0.2 ng/ml after surgery. The evaluation
of urinary function outcome was performed using the
International Prostate Symptom Score (IPSS) and number
of daily pad use, and that of sexual function outcome
using the International Index of Erectile Function (IIEF)-
erectile function (EF) domain score (questions 1–5 and
15). The data of urinary and sexual function outcome
were collected using questionnaires. The detail of the
study was explained to each of patient, and written in-
formed consent was received from all the patients. This
study was approved by the institutional review board at
Tottori University Faculty of Medicine and conducted in
accordance with Declaration of Helsinki.
Statistics
The comparisons of IPSS and IIEF-EF domain scores
among different groups at the same time points were
analyzed using the Mann–Whitney U test. The com-
parisons of those scores at different time points in one
group were analyzed using the Wilcoxon signed-rank and
Friedman tests.
Department: Urology   
Surgery type: Robot-assisted radical prostatectomy   
(Limited lymphadenectomy)  
1) Standard operation time: 5   hours      
2) Basal condition of termination order
a) Breakdown or malfunction of robotic surgical system
b) Malfunction of robotic surgical equipment
c) Excess bleeding: more than    2000       ml        
d) Excess operating time: more than       8     hours       
3) Other conditions of the termination order
a) When operators recognize unexpected intra-operative 
findings of advanced cancer
b) When it is obvious that other organ injuries occur
c) When anesthetists recognize critical problem in the 
general care of the patient
Department: Digestive Surgery             
Surgery type: Robot-assisted low anterior resection
1) Standard operation time: 6    hours      
2) Basal condition of termination order
a) Breakdown or malfunction of robotic surgical system
b) Malfunction of robotic surgical equipment
c) Excess bleeding: more than    500       ml        
d) Excess operating time: more than     10      hours       
3) Other conditions of the termination order
a) When operators recognize the difficulty of proceeding 
with the operation based on an anatomical abnormality 
or adhesion
b) When anesthetists recognize a critical problem in the 
general care of the patient
Figure 1 The termination order (English version) for RARP and low anterior resection are shown. The original documents are described
in Japanese.
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Case number results in the MISC
The case number results in the MISC as of December 31,
2012 are shown in Table 1. Each surgery type in Table 1
had been certified by the MISC. The certified committee
surgeons included two from urology, one from gynecology,A)
B)
Figure 2 The inside views and equipment of the MISC robotic-operat
has six fixed monitors and one movable monitor. The six fixed monitors in
movable monitor is 46 inch in size. Four sets of 32 inch size fixed monitorsone from respiratory surgery and two from the digestive
surgery departments.
Application of medical insurance for RARP
The use of any type of medical insurance was not applicable
from October in 2010 until August in 2011. For insuranceing theater are shown. A) The floor space is 98 m2. B) This theater
clude two sets of 70 inch and four sets of 32 inch-sized monitors. One
and one movable monitor are capable of 3D display.
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Table 2 Pre-operative patients’ characteristics
No. patients 100
Continuous variables; mean (range)
Age (ys) 64.6 (48 – 76)
BMI (kg/m2) 23.8 (18.0 – 35.4)














0 – 7 53
8 – 19 34
20 - 35 13
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were applicable from August in 2011 until March in 2012.
Japanese medical insurance has been applicable for RARP
from April in 2012.
Patients’ characteristics
The pre-operative patients’ characteristics are shown in
Table 2. We defined the indication for RARP as localized
prostate cancer; however, the National Comprehensive
Cancer Network (NCCN) high-risk cases were considered
as eligible in our policy after careful consideration in each
case. In those cases, a wide resection of prostate together
with extended lymphadenectomy was performed. Pre-
operative assessment of PCa consisted of a digital rectal
examination, radiological examinations including mag-
netic resonance imaging and computed tomography using
contrast material, and trans-rectal ultrasound. The find-
ings of these examinations were reflected in the pre-
operative staging of PCa in each case. The staging of PCa
was according to the International Union Against Cancer
standards (Seventh Edition). Previous abdominal surgeries
either open or laparoscopic were eligible for RARP in our
policy.
Surgical procedure
Although surgical procedures were performed using a
transperitoneal, 6-port technique based as previously de-
scribed [7], modifications that considered aspects of our
anatomical research were employed [8]. The anastomosis
was performed as described by Van Velthoven et al. [9]
with modifications. Nerve sparing procedures were per-
formed using a similar method according to the four
grades of postero-lateral resection of the prostate [10]:Grade 1, intrafascial dissection; Grade 2, interfascial dis-
section; Grade 3, extrafascial dissection (partial nerve
sparing), and Grade 4, wide dissection.
Operating time transition
The procedures in first 32 cases were performed by a sin-
gle surgeon (A.T.) with considerable experience in open
(ORP) and laparoscopic radical prostatectomy (LRP). Sub-
sequently, a second pair (2 surgeons) of certificated sur-
geons entered into performing console procedures using
step-by-step methods under the supervision of A.T. From
the case number 71, another two certificated surgeons
also entered into these procedures. The second and third
pairs of certificated surgeons only had experience with
ORP but not with LRP. The mean (range) total operative
and console time except for the cases of extended lymph-
adenectomy in single surgeon (A.T.), the first pair and the
second pair of his trainee doctors were 331 (225–575),
334 (251–409), 354 (307–399) and 244 (160–479), 249
(168–318), 273 (215–319) minutes respectively.
Peri- and post-operative complications
There were no cases that required a conversion to open
surgery, or intra-operative complications which required
additional surgical procedures and intra-operative blood
transfusions. Post-operative major complications included
one patient who had bleeding from the neurovascular
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located in abdominal muscle (Clavien II). Post-operative
minor complications included eight patients with subcuta-
neous emphysema, five with anastomotic leaks, four with
subcutaneous hemorrhages, two with ileus, two with lym-
phocele and seven cases with other complications. All
minor complications were categorized as Clavien I.
Oncological outcomes
Post-operative pathological characteristics are shown in
Table 3. The positive surgical margin (PSM) rate defined
by the presence of cancer cells at the inked margin was
19% for the entire series and was 10.7% for pT2, 42.9%
for pT3a and 50% for pT3b disease. Additionally, 57.9%
of PSM cases had extra-capsular extension disease. Bio-
chemical recurrence (BCR) was observed in 9% of the
entire patient series, and four patients (44.4%) had both
a Gleason score 9 and lymph node metastases.
Pre- and post-operative sequential transitions of urinary
function
The sequential transitions of pre- and post-operative
IPSS are shown in Figure 3. One month post-operative
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Multifocal 2(P = 0.0011); however, significant improvements were
observed three months post-operatively (P < 0.0001),
and improvements continued until 24 months post-
operation [Figure 3A]. When the patients were divided
into two groups based on the severity of pre-operative
IPSS, contrasting transition values were seen between
the moderate to severe (8–35 points) and mild (0–7
points) groups [Figure 3B]. Specifically, consistent im-
provements were observed in the moderate to severe
group throughout follow-up duration (pre- vs. three
months post operation; P = 0.0005). In contrast, one
month post-operative IPSS were significantly higher than
pre-operative values (P < 0.0001); however, significant
improvements were observed three months post oper-
ation (P = 0.0001) in the mild group. With regard to
urinary continence evaluation, post-operative continence
was defined as no use of pad per day. The continence re-
covery rates immediately after catheter removal, 1, 3, 6,
9, 12, 18 and 24 months post operation were 27, 41, 60,
69, 71.2, 81.4, 78.1 and 100%, respectively [Figure 4].
The analysis of potency recovery according to the grade
of neurovascular preservation
Potency recovery in the patients with no (IIEF-EF do-
main score; 26 – 30) and mild (IIEF-EF domain score;
22 – 25) erectile dysfunction before surgery were ana-
lyzed sequentially [Figure 5A]. Because of limited patient
numbers, grades 1 and 2 were included in the same cat-
egory of total nerve sparing. Grades 3 and 4 were cate-
gorized as partial and non-nerve sparing, respectively. In
the analysis of bilateral- and unilateral total, and bilateral
partial nerve sparing groups, these three groups demon-
strated similar transitions; a sharp decrease of EF domain
scores one month post-operation and improvements
thereafter [Figure 5B]. The three month post-operative
scores were significantly higher than the one month post-
operative scores in the unilateral total nerve sparing group
(P = 0.005). In comparison of scores among the three
groups, bilateral- and unilateral total nerve sparing groups
revealed higher scores than those of the partial nerve spar-
ing group post-operation for all time points. This charac-
teristic is significant at the one (bilateral total vs. bilateral
partial; P = 0.0472) and six (unilateral total vs. bilateral
partial; P = 0.0451) month post-operative time points.
Discussion
Compared with the conventional laparoscopic technique,
RARP provides the advantages including increased de-
grees of freedom and maneuverability, a three dimensional
(3D) view with magnification, and a filtered tremor [11].
Apart from the innovative improvements of surgical tech-
niques, the robotic program requires team-based training
not only for surgeons but also for other medical staff who























1 3 6 9 12 18 24
All cases Moderate to severe group 
(8 – 35 points) (n = 47)
Mild group 




Figure 3 The sequential transitions of pre- and post-operative IPSS were shown. A) Total cases, and B) Patients divided into two groups
according to the severity of pre-operative IPSS; Moderate to severe group, 8–35 points; Mild group, 0–7 points.
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nurses is necessary for the successful implementation
of robotic surgery [12]. To accommodate the robot,
the operation theater required renovation. To the best of
our knowledge, the MISC is the first comprehensive
organizational institution that runs robotic surgeries and
spans over four different surgical departments. Moreover,
the MISC is a renovated operating theater that covers a
large area and has a sufficient numbers of wide 3D
monitors for viewing by assistant surgeons and otherP
U













Figure 4 The post-operative continence recovery rates at precise timobservers. One notable issue, other than surgical skills
and its correlation to patient outcome, is how to run
a robotic surgery effectively from the aspects of cost,
education and safety. Simple modifications in operat-
ing room processes were suggested to be associated
with reduced costs and time for RARP [13]. Although
large amounts of funding were necessary to begin the
MISC, we believe that the cost-efficiency and educa-
tional benefit of running a robotic surgeries theater
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Bilateral total nerve 
sparing (n = 4)
Bilateral partial nerve sparing (n = 5)
Unilateral total nerve 




Figure 5 The sequential transitions of pre- and post-operative IIEF-EF domain scores in patients with no and mild erectile dysfunction
before surgery are shown. A) Total cases, and B) Patients divided into three groups according to the status of neurovascular
sparing procedures.
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experience in ORP and LRP, and successfully demon-
strated a learning curve over the first 10 to 20 cases
(data not shown in this article). This result is in accord-
ance with the previous study in which the learning curve
of an experienced open yet naïve laparoscopic surgeon
demonstrating 4-hours surgical proficiency was 12 cases
[14]. Because RARP is a team-based surgery, the assis-
tant’s skills might have influenced the learning curve of
our team. The introduction of 3D monitors for first as-
sistant from case No. 9 might have contributed to the
successful learning curve of our team because the first
assistant had no experience of LRP. In contrast, if the
learning curve was linked to the improvement of posi-
tive surgical margin rate, it was demonstrated that this
started to plateau after 1000–1500 cases [15]. Because
the new pentafecta concept is considered to be the re-
cent true goal of RARP, the learning curve should not be
discussed only with regard to the issue of operating
time.
The following paragraphs discuss the issue of pentafecta.
1) Peri-operative complications: Our study demonstrated
no cases in which intra-operative open conversion was re-
quired. A previous study reported seven cases of open
conversion in their initial 100 cases of RARP, and five of
those cases were due to surgical procedures problems
[16]. The complication rate according to Clavien classifi-
cation of our study is comparable with that of a previous
study of 200 initial cases reported by Jeong et al.; however,
the rate of severe complications other than Clavien I
was much less in our study when compared with that re-
port [17]. The structured program for the certification ofconsole surgeons in the MISC and our original step-by-
step training program referenced by a previous study [18]
has been suggested to minimize the severe complications
and the requirement of open conversion operations. 2)
BCR and PSM rate: Because the follow-up duration is
relatively short in our patient cohort, oncological control
was only been evaluated by PSM rate to date. The entire
PSM rate of 19% in our study is compatible to those of
previous studies in initial patient cohort of 50–200 cases
which demonstrated PSM rates of 30 [19], 16 [16], 23 [20]
and 10.5 [7] %, respectively. More than half of our patient
cohort did MRI examinations before the prostate biopsy.
This pre-operative examination procedure enabled us to
accurately detect cancer foci, and consequently led to an
appropriate surgical policy with an excision range. We
believe that an appropriate surgical policy and precise
intra-operative procedures will contribute to lower
the PSM rate as our experience increases. 3) Urinary
function outcome: The natural history of urinary func-
tional transition after RARP is currently poorly described.
Our results demonstrate significant improvement of IPSS
3, 6, 12 months after RARP compared with that at pre-
operative base-line in moderate to severe IPSS cases
are accordance with the previous study [21]. This post-
operative trend of IPSS improvement in moderate to se-
vere IPSS cases was also demonstrated in ORP including
retropubic [22] and perineal [23] approaches. As men-
tioned for ORP, RARP is suggested to also have a signifi-
cant beneficial effect on lower urinary tract symptom
(LUTS) beyond cancer control. Our results of continence
recovery are compatible with the a recent review of a
meta-analysis that demonstrated the 12-month urinary
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value of 16% not using a defined pad [24]. They concluded
that the prevalence of post-operative continence is influ-
enced by various factors including preoperative patient
characteristics, surgeon’s experience, surgical technique,
and methods used to collect and report data [24]. 4) Po-
tency: The transition of post-operative potency recovery
rate in patients treated by nerve sparing procedures were
assessed at almost similar post-operative time points of 3,
6, and 12 months [6,25-27]. These studies demonstrated
the effect of bilateral nerve sparing when using the defini-
tions of either the Sexual Health Inventory for Men
(SHIM) or an erection sufficient for intercourse. Although
our data number are not sufficient to indicate significant
conclusions, this is the first report to include additional
detailed data with regard to more precise post-operative
time points and according to three different types of nerve
sparing procedures. We are continuing to collect data re-
garding these issues, and we believe that the definitive
conclusions of precise post-operative transitions according
to various types of nerve sparing procedures (three grades
of preservation multiplying bi- or unilaterally) will be gen-
erated in the near future.
Conclusions
This is the first report of an initial 100 RARP cases im-
plemented in the constitutional framework of an academic
institution. The MISC are providing immeasurable bene-
fits from the aspects of patient safety and education for
the robotic surgical team. RARP is a safe and efficient
method for achieving PCa control along with functional
preservation even during the initial experience for this
procedure.
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